SNES SenesTech, Inc.
Agricultural Chemicals · Nasdaq · SEC CIK 1680378 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY20.9%
TTM net income YoY-31.2%
TTM EPS YoY41.2%
Revenue 3-yr CAGR32.5%
Net income 3-yr CAGR—
Margins
Gross margin69.5%
Operating margin-282.4%
Net margin-275.3%
FCF margin-239.3%
EBITDA margin-277.8%
Returns
ROE-96.0%
ROA-67.2%
ROIC (approx.)-263.0%
Asset turnover0.24x
Leverage & solvency
Liabilities / assets43.5%
Debt / equity0.00x
Current ratio4.51x
Interest coverage-413.32x
Cash quality & payout
Operating cash flow / net income0.87x
Accruals ratio-9.1%
Payout ratio—
Capex / revenue1.1%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $1.10M | $770,000 | $493,000 | $421,000 | $690,000 | $625,000 | $485,000 | $501,000 |
| Cost of revenue | $301,000 | $203,000 | $155,000 | $188,000 | $257,000 | $216,000 | $172,000 | $196,000 |
| Gross profit | $796,000 | $567,000 | $338,000 | $233,000 | $433,000 | $409,000 | $313,000 | $305,000 |
| R&D expense | $418,000 | $377,000 | $422,000 | $453,000 | $400,000 | $427,000 | $418,000 | $424,000 |
| SG&A expense | $1.29M | $2.05M | $2.04M | $1.66M | $955,000 | $1.60M | $1.56M | $1.14M |
| Operating income | -$1.99M | -$1.86M | -$2.12M | -$1.88M | -$1.35M | -$1.61M | -$1.66M | -$1.26M |
| Interest expense | $5,000 | $5,000 | $4,000 | $5,000 | $6,000 | $6,000 | $5,000 | $7,000 |
| Net income | -$1.96M | -$1.83M | -$2.06M | -$1.80M | -$1.30M | -$1.62M | -$1.67M | -$1.25M |
| EBITDA | -$1.96M | -$1.83M | -$2.09M | -$1.85M | -$1.32M | -$1.58M | -$1.62M | -$1.22M |
| EPS (basic) | -0.36 | -0.35 | -0.39 | — | -0.28 | -0.87 | -1.28 | — |
| EPS (diluted) | -0.36 | -0.35 | -0.39 | — | -0.28 | -0.87 | -1.28 | — |
| Weighted avg. shares (diluted) | 5.42M | 5.30M | 5.26M | — | 4.67M | 1.85M | 1.30M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $3.95M | $5.08M | $6.80M | $7.58M | $7.28M | $6.05M | $1.66M | $1.31M |
| Short-term investments | $0 | $0 | $0 | $994,000 | $2.97M | — | — | $0 |
| Receivables | $247,000 | $361,000 | $163,000 | $201,000 | $454,000 | $470,000 | $498,000 | $335,000 |
| Inventory | $966,000 | $969,000 | $1.05M | $994,000 | $767,000 | $711,000 | $753,000 | $794,000 |
| Current assets | $5.56M | $6.78M | $8.35M | $10.06M | $11.78M | $7.47M | $3.16M | $2.81M |
| PP&E, net | $334,000 | $348,000 | $379,000 | $410,000 | $429,000 | $416,000 | $404,000 | $407,000 |
| Total assets | $8.14M | $9.42M | $11.06M | $12.84M | $14.62M | $10.37M | $3.63M | $3.28M |
| Current liabilities | $1.23M | $1.00M | $938,000 | $798,000 | $748,000 | $810,000 | $543,000 | $561,000 |
| Total liabilities | $3.54M | $3.37M | $3.36M | $3.27M | $3.28M | $3.39M | $734,000 | $767,000 |
| Shareholders' equity | $4.60M | $6.05M | $7.70M | $9.57M | $11.35M | $6.98M | $2.89M | $2.51M |
| Shares outstanding | 5.48M | 5.30M | 5.30M | 5.22M | 5.22M | 3.76M | 1.78M | 1.04M |
| Cash flow statement | ||||||||
| Operating cash flow | -$1.32M | -$1.71M | -$1.93M | -$1.66M | -$1.38M | -$1.15M | -$1.56M | -$1.22M |
| Capital expenditure | $18,000 | $0 | $0 | $13,000 | $42,000 | $47,000 | $36,000 | $15,000 |
| Free cash flow | -$1.34M | -$1.71M | -$1.93M | -$1.68M | -$1.42M | -$1.20M | -$1.59M | -$1.23M |
| Investing cash flow | -$18,000 | $0 | $1.00M | $1.99M | -$3.01M | -$47,000 | -$36,000 | -$15,000 |
| Financing cash flow | $211,000 | -$15,000 | $158,000 | -$26,000 | $5.61M | $5.60M | $1.94M | $22,000 |
| Depreciation & amortization | $32,000 | $31,000 | $31,000 | $32,000 | $29,000 | $35,000 | $39,000 | $41,000 |
| Stock-based compensation | $276,000 | $182,000 | $23,000 | $36,000 | $47,000 | $90,000 | $91,000 | $80,000 |
Free plan shows the latest 8 periods; Pro shows all 43 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.